Immunotherapy for Prostate Cancer – Dr Nicola Annels
Cancer immunotherapy is one of the newest and most promising of cancer treatments.
Cancer immunotherapy is one of the newest and most promising of cancer treatments.
Some forms of cancer can become resistant to hormone therapy.
The best strategies for new treatment remain to be defined, but we need to look beyond traditional chemotherapy and radiotherapy.
Celebrating the 10th Anniversary of Cancer Research at the University of Surrey On 29th January 2016, the Prostate Project celebrated 10 years of campaigning which has helped put Surrey at the forefront of the fight against cancer. In 2006 the Prostate Project jointly established and funded a research group with the University of Surrey, led by
Clinical trials have found that the EN2 biomarker test is twice as effective as the PSA blood test currently used to detect prostate cancer.
The SUN study is an example of a successful project delivered with the support of Prostate Project charity.
Potential targets for novel therapies include proteins involved in cell growth and signalling within the cell.